# Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins

> **NCT00082355** · PHASE2 · COMPLETED · sponsor: **Richard Chang, M.D.** · enrollment: 30 (actual)

## Conditions studied

- Acute Deep Venous Thrombosis of the Lower Extremity

## Interventions

- **DRUG:** Alteplase (Activase, Genentech)

## Key facts

- **NCT ID:** NCT00082355
- **Lead sponsor:** Richard Chang, M.D.
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2010-03
- **Final completion:** 2014-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082355, "Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00082355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*